Not sure if this has been covered here before, but apparently researchers at Rochester have recently discovered how enzalutamide can cause neuroendocrine differentiation in castrate resistant prostate cancer cells.
https://m.medicalxpress.com/news/2019-06-prostate-cancer-molecular-prolong-survival.html